Icon
+91 94997 68112
Login Register

JAKAFI XR - (EQ 11MG BASE; TABLET,EXTENDED RELEASE)

RUXOLITINIB PHOSPHATE None
EQ 11MG BASE; TABLET,EXTENDED RELEASE
Less Than $1000 mn
None None
None None
None None
JAKAFI/JAKAFI XR is a kinase inhibitor indicated for treatment of:  intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis, and post-essential thrombocythemia myelofibrosis in adults.  polycythemia vera in adults who have had an inadequate response to or are intolerant of hydroxyurea.  steroid-refractory acute graft-versus-host disease in adult and pediatric patients 12 years and older.  chronic graft-versus-host disease after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older.
Yes

JAKAFI XR - (EQ 22MG BASE, EQ 33MG BASE, EQ 44MG BASE, EQ 55MG BASE; TABLET,EXTENDED RELEASE)

RUXOLITINIB PHOSPHATE None
EQ 22MG BASE, EQ 33MG BASE, EQ 44MG BASE, EQ 55MG BASE; TABLET,EXTENDED RELEASE
Less Than $1000 mn
None None
None None
None None
JAKAFI/JAKAFI XR is a kinase inhibitor indicated for treatment of:  intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis, and post-essential thrombocythemia myelofibrosis in adults.  polycythemia vera in adults who have had an inadequate response to or are intolerant of hydroxyurea.  steroid-refractory acute graft-versus-host disease in adult and pediatric patients 12 years and older.  chronic graft-versus-host disease after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older.
Yes

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.